^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^e Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^f Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^g Salt not specified.

^h Tested with fentanyl citrate (TER) 0.05 mg/mL.

ⁱ Tested with remifentanil HCl (DSC) 0.1 mg/mL.

^j Tested with remimazolam besylate (MUN) 5 mg/mL.

^k Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.

^l Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^m Intralipid product.

ⁿ SMOFlipid product.